An engineered cell can place a payload under the control of a naturally regulated gene. The resulting expression pattern still needs measurement in the actual cells and tissues.
A CRISPR knock-in can connect an engineered cytokine payload to regulatory control at an endogenous gene locus. In preclinical work, NR4A2 and RGS16 control supported cytokine expression in specified CAR T-cell settings, with tumor and safety measurements in mouse models. This is distinct from adding synthetic response elements to a separate promoter. Neither the locus name nor an activation-responsive design proves tumor-only secretion, clinical safety or patient benefit.
Shares Cellular kinetics and persistence, Armoured, logic-gated & next-gen CARs.
Shares Cellular kinetics and persistence, Armoured, logic-gated & next-gen CARs.
Shares Cellular kinetics and persistence, Armoured, logic-gated & next-gen CARs.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/